Endra Life Sciences Inc (NDRA)

[Adrock]

Should we Scooooooop of DUMP here???

[biotech_researcher]

You have your chance again..

[dndodd]

I agree bought a bunch in the pre-market when it dipped into the .60’s last week. They just need FDA and sales.

[Marksch1]

Im already disgusted I didn't buy more on that pullback. Sure looks like it wants to creep back up

[Rogerthat1]

Them Vietnamese livers need to be scanned imo at bedside

[Rogerthat1]

Pricing out. 70¢ - $5M in the bag for Wells to go procure some parts to build some systems

[dndodd]

Not sure but I did.

[Marksch1]

Taking a long term view, is there any reason I wouldn't want to pick a few more shares up at .67 ??

[Marksch1]

Yeah i see that finally. Yeah their timing sucks.

[dndodd]

An offering. Which was extremely bad timing. IMO

[Marksch1]

What the hell happened after hours?

[dndodd]

I don’t.

[Marksch1]

You guys have any explanation for all the odd price movements in the after and pre markets? Seems pretty odd

[Tonyboons33]

Nice to hear about the Vietnam news today. We seem to be trending in the right direction!

[dndodd]

You caught the bottom I have been buying under .85.

[Marksch1]

I got a lousy 141 share fill at .78 today.
Was hoping for 1000

[dndodd]

True most of it happens in the market I can think of 2 other instances like this. In one of the previous ones the PR was released at 6;00AM. They have gone to releasing their PR’s later today’s was at 8:20am CST and games were still played.

[Tonyboons33]

It's definitely more than just today though. Seems to happen often... weird.

[dndodd]

Everyone knows FDA news is expected I think the algos just over reacted to this news.

[Tonyboons33]

You guys notice at all that it seems every morning we've got a spike in SP and then is quickly comes crashing down? Even with good news today... just seems like a recurring theme that price starts high most mornings or even end of day and then there's a selloff. Curious your thoughts...

[dndodd]

I saw that it is unusual .88 -.95 but only around 3,000 shares.

[Marksch1]

We up to 95 cents in after market. Something going on ?

[Marksch1]

Unfortunately was not me

[dndodd]

it looked like somebody picked 1200 at .78 in the pre-market.

[Marksch1]

I have a constant buy order in at .78 now.
If it gets filled I add a new one. Seems to be working pretty well for the time being. I've gotten a bunch filled

[dndodd]

Wait until there is some good news which should be soon. This may have been generated by someone taking a big position in the warrants NDRAW.

[Marksch1]

This thing went from 90 cents to 80 cents in what, 20 minutes? Crazy shit

[Marksch1]

Based on the chart pattern, 2 high vol up days followed by a flag/pennant formation, next move up if we do break out is to about a buck. TA doesn't always work with these penny stocks though.

[dndodd]

I was trying to the same.

[Marksch1]

I can see that. I tried to pick some up at .78 this afternoon but unsuccessful. Left the order open though

[dndodd]

The virus has significantly slowed their efforts in Europe.

[Marksch1]

Seems like, with the market cap so small, most people agents giving the CE Mark much value.

[dndodd]

I think the Robarts Trial played into getting the CE and FDA.

[Marksch1]

What did they have to do to get the CE Mark? Were there clinical trials involved or is it just a matter of the product not harming anybody and you get the CE?

[dndodd]

I agree I think the key is one of the coming catalysts most likely the FDA approval when it happens.

[Marksch1]

Thanks for that. Finally had a half hour to check it out, that's a pretty impressive presentation. Im still adding under 80 cents. Seems like the share price does mice nicely on news.

[Tonyboons33]

Love it. I'm long and excited about the presentation and the potential!

[dndodd]

It is also in Ivins, UTAH and that is where the trail will occur. It took me literally 5 seconds to verify that.
"Rocky Vista University is a private, for-profit osteopathic medical school with campus locations in Parker, Colorado and Ivins, Utah. The school opened in 2006 as the only modern for-profit medical school in the United States, although several other for-profit schools have since opened. Wikipedia"

The efficacy will be proven by the trial as it should be.

Extensions are easy to come by witht he NASDAQ not a big concern. Just need to get the stock over $1.00 for 10 days should happen easily with any of the multiple catalysts about to happen.

FDA approval, Sales, Trials, Partnerships, New Ge agreement,etc

[Tonyboons33]

I thought it was a great presentation and mgmt did a good job of explaining the product, the need within the industry, and how they plan to go about positioning themselves as a cost effective point of case resource for clinicians. What I don't know and I think what scares me is the accuracy of efficacy % of their product and whether or not it's tolerable within the industry. I also found it interesting that CEO said their actual install at Rocky Mountain Vista would be better than their "prototype". Would have been nice for him to elaborate how the TAEUS installed at Rocky Mountain was superior.

Did anyone else notice that he referenced what I believe is Rocky Mountain Vista being in Utah? It's in CO, he should know that.

Market cap is SCARY low which is very concerning. Also would have liked them to touch upon the NASDAQ compliance issue and how they intend to get back into compliance. Does anyone know when they have until?

[dndodd]

https://www.webcaster4.com/Webcast/Page/2038/38413

[Marksch1]

Have you got a link to that virtual presentation?

[biotech_researcher]

There is a reason the market cap is minuscule.....

[Marksch1]

I shall. Thanks

[dndodd]

Listen to today's presentation

[Marksch1]

I might get my .80's filled yet. Dipped down to 82 cents earlier

[dndodd]

Personally I hope not. Lol
Got my last fills under .70 a few days ago.

[Marksch1]

Looks like that won't happen, but I adjusted my order to 80 cents to add to my long term position. Might not get that filled either.

[Marksch1]

Yes it is. Im hoping to pick up some more around 70 cents with a little luck.

[Tonyboons33]

This is niiiiice!

ANN ARBOR, MI / ACCESSWIRE / November 12, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today announced that Rocky Vista University College of Osteopathic Medicine ("RVUCOM") has begun scanning patients in its clinical study of ENDRA's Thermo-Acoustic Enhanced Ultrasound (TAEUS?) clinical system to assess Non-Alcoholic Fatty Liver Disease ("NAFLD"). The studies are being conducted at RVUCOM's Ivins, Utah location will be the first real-world cases to be performed with TAEUS in the U.S.

ENDRA has received the CE mark to sell the TAEUS system in Europe, and is awaiting clearance by the U.S. Food and Drug Administration for its 510(k) application to begin sales in the U.S. The data from the RVUCOM study, along with other announced and future studies, will be used to further build the clinical evidence base and establish the clinical utility of the TAEUS system in patients with NAFLD to support current and future commercialization efforts.

The goals of the RVUCOM study, include:

Comparing results obtained with ENDRA's commercial design TAEUS liver device against a baseline measure of liver fat as determined by MRI-PDFF (magnetic resonance imaging proton density fat fraction);
Scanning a target of 200 volunteers including fatty liver patients and healthy controls to contribute additional diversity and volume of patient data; and,
Providing ENDRA with ongoing clinical feedback regarding TAEUS product design, clinical workflow and clinical performance.
The principal investigator in the RVUCOM study, Jing Gao, M.D., who is a member of ENDRA's scientific advisory board ("SAB"), commented, "This is an exciting step for ENDRA and for Rocky Vista University as we advance use of the TAEUS platform in a real-world clinical setting. We believe TAEUS has the potential to address a significant unmet clinical need for the robust, practical, non-invasive assessment of liver fat."

"Working with RVUCOM and other leading clinical reference sites is an essential part of building our base of clinical evidence to support commercialization efforts for TAEUS," said ENDRA Chief Commercial Officer Renaud Maloberti. "We look forward to supporting and learning from RVUCOM, as well as other medical facilities that will be evaluating TAEUS."

[dndodd]

This should do to mid 1’s quickly easily with good news. IMO